No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Earnings Call Summary | MEDEXUS PHARMACEUTICALS INC(MEDXF.US) Q4 2024 Earnings Conference
Medexus Generates Record Revenue of US$113.1 Million in Fiscal Year 2024
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call
Canadian Investment Regulatory Organization Trade Resumption - MDP
FDA Accepts for Review Treosulfan NDA Resubmission
With A Return On Equity Of 20%, Has Medexus Pharmaceuticals Inc.'s (TSE:MDP) Management Done Well?